title: [Differential effect of glucosaminylmuramyl dipeptide on the phenotype of melanoma sublines with different metastatic potential].
authors.forename: T I
authors.initials: TI
authors.lastname: Valiakina
authors.forename: A A
authors.initials: AA
authors.lastname: Malakhov
authors.forename: R L
authors.initials: RL
authors.lastname: Komaleva
authors.forename: E E
authors.initials: EE
authors.lastname: Petrova
authors.forename: A D
authors.initials: AD
authors.lastname: Mikhaĭlov
authors.forename: E S
authors.initials: ES
authors.lastname: Revazova
authors.forename: V A
authors.initials: VA
authors.lastname: Nesmeianov
mesh_terms: D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000494:pharmacology*; D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D000954:Antigens, Surface / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D006801:Humans; D008546:Melanoma, Experimental / Q000235:genetics* / Q000276:immunology / Q000473:pathology; D051379:Mice; D008819:Mice, Nude; D009362:Neoplasm Metastasis / Q000235:genetics* / Q000276:immunology; D009368:Neoplasm Transplantation; D010641:Phenotype; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured; D019139:Tumor Escape
chemical_list: D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D000119:Acetylmuramyl-Alanyl-Isoglutamine